• Omeprazole (A2845): Technical Guide for Gastric Acid Studies

  2026-07-30

  Omeprazole (A2845) provides a validated, high-purity H+,K+-ATPase inhibitor for controlled studies of gastric acid secretion and antiulcer activity. It is strictly intended for in vitro and ex vivo research workflows and should not be used for diagnostic, medical, or therapeutic purposes.

• ATP Solution in mRNA Assays: Workflow Enhancements & Insight

  2026-07-30

  Harnessing ATP Solution (100 mM) unlocks robust, reproducible kinase and in vitro transcription workflows essential for advanced mRNA-based therapies. Explore protocol upgrades, troubleshooting, and direct translational insights from pioneering p21 mRNA-LNP bladder cancer studies.

• Applied Actinomycin D: Optimizing Transcriptional Inhibition

  2026-07-29

  Actinomycin D empowers researchers with precision transcriptional inhibition for mRNA stability analysis, apoptosis induction, and DNA damage response workflows. This evidence-backed guide details advanced applications, protocol enhancements, and troubleshooting strategies to maximize reproducibility and sensitivity in cancer research and molecular biology.

• VX-765: Precision Caspase-1 Inhibition for Inflammation Rese

  2026-07-29

  VX-765, a potent and selective caspase-1 inhibitor, empowers researchers to dissect inflammasome-driven pathways and pyroptosis in both cellular and animal models. With robust selectivity for IL-1β and IL-18 suppression and proven translational value, VX-765 streamlines experimental workflows for inflammation, autoimmunity, and infectious disease research.

• Brefeldin A: ATPase Inhibitor for ER Stress and Cancer Resea

  2026-07-28

  Brefeldin A (BFA) is a potent ATPase inhibitor and ER stress inducer that disrupts vesicle transport, making it a foundational tool for cancer and cell biology research. BFA's precise inhibition of ER-to-Golgi trafficking enables direct study of apoptosis and cytoskeletal dynamics in tumor models. Its utility is supported by robust benchmarks and verified protocols.

• UBR1 and UBR2 as Central ER Stress Sensors in Mammals

  2026-07-28

  This study reveals UBR1 and UBR2 as key E3 ubiquitin ligases stabilizing mammalian cells against ER stress. Their regulation adds a new layer to our understanding of protein quality control, with implications for ER stress-related apoptosis and disease models.

• Brefeldin A in Experimental Protocols: Precision ER Stress I

  2026-07-27

  Brefeldin A (BFA) offers precision control over vesicular trafficking and ER stress in diverse cell biology workflows, enabling reproducible apoptosis induction in cancer and endothelial models. Discover how APExBIO's BFA streamlines experimental design, helps dissect cytoskeletal dynamics, and delivers actionable troubleshooting strategies for robust, publication-ready data.

• PPT1 and ZDHHC7 Regulate Palmitoylation in Cisplatin-Resista

  2026-07-27

  This study defines a novel regulatory mechanism in osteosarcoma, demonstrating that the palmitoylation cycle of Sprouty 4, controlled by PPT1 and ZDHHC7, drives cisplatin resistance through MAPK signaling modulation. Targeting PPT1 with the inhibitor GNS561 restores cisplatin sensitivity in resistant OS cells, offering a promising therapeutic avenue and opening new directions for precision oncology research.

• CAY10499: Potent HSL & MGL Inhibitor for Reliable Lipid Assa

  2026-07-26

  This article details how CAY10499 (SKU B7841), a potent inhibitor of human hormone sensitive lipase and monoglyceride lipase, addresses reproducibility, selectivity, and workflow optimization challenges in lipid metabolism assays. Drawing on peer-reviewed literature and real-world scenarios relevant to cell viability and immunometabolic research, it offers best-practice guidance for leveraging CAY10499 in advanced laboratory workflows.

• IWP-L6: Strategic Porcupine Inhibition in Translational Wnt

  2026-07-25

  Explore how precision Porcupine inhibition with IWP-L6 unlocks new frontiers in Wnt signaling modulation, bridging mechanistic insight and translational strategy. This article synthesizes emerging evidence on metabolic rewiring in bone formation, provides expert protocol guidance, and positions IWP-L6 from APExBIO as an essential tool for researchers seeking robust, reproducible outcomes in developmental and regenerative biology.

• Sodium Oxamate: Strategic Disruption of Cancer Metabolism

  2026-07-24

  Explore how Sodium Oxamate empowers translational researchers to interrogate metabolic reprogramming and lactylation-driven resistance in aggressive cancers, with mechanistic insights and strategic guidance for experimental design.

• JSH-23: Precision NF-κB Inhibitor for Inflammation Research

  2026-07-24

  JSH-23 offers researchers a robust, selective tool for dissecting NF-κB-driven inflammatory pathways in both cellular and animal models. Its unique mechanism—blocking p65 nuclear translocation—enables high-fidelity investigation of cytokine regulation and acute injury responses, distinguishing it from conventional NF-κB inhibitors.

• Azilsartan (SKU B2210): Enabling Reproducible RAS–SIRT3 Rese

  2026-07-23

  Azilsartan (SKU B2210) from APExBIO delivers highly specific, DMSO-soluble AT1 receptor inhibition, empowering more reproducible studies of the renin-angiotensin system (RAS) and neuroinflammation. This article addresses common experimental challenges, interprets quantitative findings, and provides practical, scenario-driven insights for advanced astrocyte–microglia and cardiovascular models.

• Reserpine (N1867): Technical Parameters for Lab Research Use

  2026-07-23

  Reserpine (SKU N1867) is a high-purity, bioactive compound designed for laboratory studies involving neurotransmitter depletion and antihypertensive mechanism research. It is not suitable for diagnostic or medical use, and its integrity relies on strict adherence to solubility and storage protocols. This guide provides actionable technical parameters and workflow recommendations to support reproducible neuropharmacology experiments.

• Filipin III: Advancing Membrane Cholesterol Visualization Wo

  2026-07-22

  Filipin III, a polyene macrolide antibiotic, is the gold standard for membrane cholesterol detection, enabling high-resolution visualization of cholesterol-rich domains in cell biology and immunometabolic research. Leveraging APExBIO’s Filipin III unlocks robust, reproducible workflows for mapping cholesterol dynamics in tumor microenvironments, with unique advantages in sensitivity and assay adaptability.

15669 records 1/1045 page Next 12345 下5页 Last page